# Carbinoxamine Maleate

NDC: 80705-120
Generic name: Carbinoxamine Maleate
Labeler / Manufacturer: TRIPOINT THERAPEUTICS, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250722

FDA application: ANDA215476

## Active ingredients

- CARBINOXAMINE MALEATE: 6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80705-120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80705-120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91ee2e99-082a-4157-b71b-1a7c0e5464fa